IceCure Stock Surges After 70% ProSense Install Increase
IceCure Medical Ltd. (NASDAQ:ICCM) shares are soaring Wednesday after the company reported a 70% jump in its U.S. commercial install base for ProSense, its breast cancer cryoablation system. Here’s what you should know. IceCure Medical stock is showing exceptional strength. What’s fueling ICCM momentum? Install Base Expands 70% After FDA Authorization IceCure announced that its active United States install base for …
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
